Diamyd Medical AB Release: Quarterly Report I 12/13
1/23/2013 6:13:54 AM
Regulatory News:
Quarterly Report 1, Diamyd Medical AB (publ) (STO:DIAMB)(Pink Sheets:DMYDY), fiscal year 2012/2013
Reporting period September 1, 2012 – November 30, 2012
• Group net sales amounted to MSEK 0 (0.2)
• Loss before tax amounted to MSEK -1.8 (-3.5)
• Earnings per share after dilution were SEK -0.2 (-0.3)
• Liquid assets and short term investments amounted to MSEK 373 (414) as of November 30, 2012
|